HomePRQR • NASDAQ
add
ProQR Therapeutics NV
$2.04
Makalipas ang Oras ng Trabaho:(1.96%)+0.040
$2.08
Sarado: Hun 27, 6:32:36 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$2.16
Sakop ng araw
$2.03 - $2.54
Sakop ng taon
$1.07 - $4.62
Market cap
214.63M USD
Average na Volume
330.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.74M | 1.74% |
Gastos sa pagpapatakbo | 15.56M | 22.16% |
Net na kita | -10.08M | -31.61% |
Net profit margin | -212.59 | -29.37% |
Kita sa bawat share | -0.11 | -10.72% |
EBITDA | -10.14M | -37.30% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 132.41M | 28.92% |
Kabuuang asset | 151.69M | 22.45% |
Kabuuang sagutin | 72.75M | -18.30% |
Kabuuang equity | 78.94M | — |
Natitirang share | 105.34M | — |
Presyo para makapag-book | 2.88 | — |
Return on assets | -16.92% | — |
Return on capital | -26.83% | — |
Cash Flow
Net change in cash
| (EUR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -10.08M | -31.61% |
Cash mula sa mga operasyon | -15.80M | -4.40% |
Cash mula sa pag-invest | -224.00K | 98.74% |
Cash mula sa financing | -500.00K | -19.33% |
Net change in cash | -16.99M | 48.83% |
Malayang cash flow | -11.93M | -10.91% |
Tungkol
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
Itinatag
2012
Website
Mga Empleyado
166
